Drug Combo Adds No Benefit in Patients with Type 2 Diabetes

Am Fam Physician. 2016 Mar 15;93(6):436-8.
No abstract available

Publication types

  • Letter

MeSH terms

  • Diabetes Mellitus, Type 2 / drug therapy*
  • Diabetes Mellitus, Type 2 / metabolism
  • Dipeptidyl Peptidase 4 / drug effects*
  • Dipeptidyl Peptidase 4 / metabolism
  • Drug Therapy, Combination
  • Glucagon-Like Peptide-1 Receptor / agonists*
  • Glucagon-Like Peptide-1 Receptor / metabolism
  • Humans
  • Hypoglycemic Agents / therapeutic use
  • Liraglutide / therapeutic use*
  • Metformin / therapeutic use*
  • Sitagliptin Phosphate / therapeutic use*

Substances

  • Glucagon-Like Peptide-1 Receptor
  • Hypoglycemic Agents
  • Liraglutide
  • Metformin
  • DPP4 protein, human
  • Dipeptidyl Peptidase 4
  • Sitagliptin Phosphate